Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Journal of Leukocyte Biology
|
October 12, 2007
Identification of the scavenger receptors SREC-I, Cla-1 (SR-BI), and SR-AI as cellular receptors for Tamm-Horsfall protein
Katharina Pfistershammer, Christoph Klauser, Judith Leitner, et al.
Molecular Therapy. Oncology
|
July 25, 2024
Co-stimulation of CD28/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness
Wannakorn Khopanlert, Pongsakorn Choochuen, Kajornkiat Maneechai, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2020
Diacylglycerol kinase ζ limits IL-2-dependent control of PD-1 expression in tumor-infiltrating T lymphocytes
Javier Arranz-Nicolás, Miguel Martin-Salgado, Cristina Rodríguez-Rodríguez, et al.
Plant Biotechnology Journal
|
December 5, 2023
Plant-derived Durvalumab variants show efficient PD-1/PD-L1 blockade and therapeutically favourable FcR binding
Shiva Izadi, Simon Gumpelmair, Pedro Coelho, et al.
Cancer Immunology, Immunotherapy : CII
|
April 10, 2021
Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program
Javier Arranz-Nicolás, Miguel Martin-Salgado, Irene Adán-Barrientos, et al.
Life Science Alliance
|
December 11, 2023
A high-throughput two-cell assay for interrogating inhibitory signaling pathways in T cells
Sumana Sharma, Toby Whitehead, Mateusz Kotowski, et al.
Nature Communications
|
November 28, 2023
Interrogating ligand-receptor interactions using highly sensitive cellular biosensors
Maximilian A Funk, Judith Leitner, Marlene C Gerner, et al.
Cancer Immunology, Immunotherapy : CII
|
June 13, 2023
Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents
Claire Battin, Annika De Sousa Linhares, Judith Leitner, et al.
Scientific Reports
|
August 9, 2019
Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
Annika De Sousa Linhares, Claire Battin, Sabrina Jutz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 19, 2015
Ig-like transcript 4 as a cellular receptor for soluble complement fragment C4d
Johannes Hofer, Florian Forster, David E Isenman, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Journal of Leukocyte Biology
|
October 12, 2007
Identification of the scavenger receptors SREC-I, Cla-1 (SR-BI), and SR-AI as cellular receptors for Tamm-Horsfall protein
Katharina Pfistershammer, Christoph Klauser, Judith Leitner, et al.
Molecular Therapy. Oncology
|
July 25, 2024
Co-stimulation of CD28/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness
Wannakorn Khopanlert, Pongsakorn Choochuen, Kajornkiat Maneechai, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2020
Diacylglycerol kinase ζ limits IL-2-dependent control of PD-1 expression in tumor-infiltrating T lymphocytes
Javier Arranz-Nicolás, Miguel Martin-Salgado, Cristina Rodríguez-Rodríguez, et al.
Plant Biotechnology Journal
|
December 5, 2023
Plant-derived Durvalumab variants show efficient PD-1/PD-L1 blockade and therapeutically favourable FcR binding
Shiva Izadi, Simon Gumpelmair, Pedro Coelho, et al.
Cancer Immunology, Immunotherapy : CII
|
April 10, 2021
Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program
Javier Arranz-Nicolás, Miguel Martin-Salgado, Irene Adán-Barrientos, et al.
Life Science Alliance
|
December 11, 2023
A high-throughput two-cell assay for interrogating inhibitory signaling pathways in T cells
Sumana Sharma, Toby Whitehead, Mateusz Kotowski, et al.
Nature Communications
|
November 28, 2023
Interrogating ligand-receptor interactions using highly sensitive cellular biosensors
Maximilian A Funk, Judith Leitner, Marlene C Gerner, et al.
Cancer Immunology, Immunotherapy : CII
|
June 13, 2023
Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents
Claire Battin, Annika De Sousa Linhares, Judith Leitner, et al.
Scientific Reports
|
August 9, 2019
Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
Annika De Sousa Linhares, Claire Battin, Sabrina Jutz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 19, 2015
Ig-like transcript 4 as a cellular receptor for soluble complement fragment C4d
Johannes Hofer, Florian Forster, David E Isenman, et al.
Page
of 8